Approval · Notice of Compliance 17934 · 2016
INDAYO: Notice of Compliance 17934
Issued March 24, 2016
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 17934
- Date
- March 24, 2016
- Company
- Mylan Pharmaceuticals UlcEtobicoke, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- Transfer of drug identification number
- Canadian reference product
- SEASONALE
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| INDAYO | 02398869 | Marketed |
Medicinal ingredients
- ETHINYL ESTRADIOL 0.03 MG per TAB
- LEVONORGESTREL 0.15 MG per TAB